J&J Q1 profit falls 10 pct despite higher sales

April 16, 2013 by Linda A. Johnson
In this Monday, July 16, 2012, photo, Johnson & Johnson products are displayed in Orlando, Fla. Johnson & Johnson reports quarterly financial results before the market opens on Tuesday, April 16, 2013. (AP Photo/John Raoux, File)

Johnson & Johnson's first-quarter profit fell by just over 10 percent as increased sales were offset by higher costs for production, marketing and administration.

The maker of Tylenol, prescription drugs and medical devices said Tuesday that it earned $3.5 billion, or $1.22 per share, down 10.6 percent from $3.9 billion, or $1.41 per share, a year earlier.

Excluding litigation and acquisition-related charges totaling $610 million, income would have been $4.1 billion, or $1.44 per share. That beat analysts' forecast by 4 cents per share.

Revenue totaled $17.5 billion, up 8.5 percent from $16.1 billion a year earlier. Analysts expected of $17.46 billion.

U.S. sales were up 11.2 percent as the company, based in New Brunswick, New Jersey, returned more of its recalled nonprescription drugs to store shelves. International sales grew by 6.3 percent.

Sales climbed 10 percent to $7.06 billion in the medical devices and diagnostics business, J&J's biggest unit. That was partly because of new products acquired last year with orthopedics device maker Synthes, J&J's biggest acquisition ever at $19.1 billion.

Prescription drug revenue rose 10.4 percent to $6.77 billion, led by Invega Sustenna for schizophrenia, three drugs for immune disorders and two new medicines likely to become blockbusters. Those are Xarelto for preventing blood clots and strokes, and prostate cancer pill Zytiga.

Sales of consumer health products edged up 2.2 percent to $3.68 billion.

Production costs jumped 13 percent to $5.55 billion, mainly for an inventory charge related to the Synthes acquisition in 2012's second quarter.

In addition, the company continues to make factory upgrades and undergoes increased regulatory inspections after issuing about three dozen product recalls since 2009, mostly for nonprescription medicines. That's kept Tylenol, Motrin and many other J&J staples out of stores until recently. But CEO Alex Gorsky said in a statement that the company is returning a reliable supply of its over-the-counter medicines to stores.

Explore further: Oracle fiscal 3Q net income up 78 pct

0 shares

Related Stories

Oracle fiscal 3Q net income up 78 pct

March 24, 2011

(AP) -- Database software maker Oracle Corp. said Thursday its net income rose 78 percent in the fiscal third quarter, helped by a rise in new software license sales and the benefit of three full months of revenue from Sun ...

Merck's 2Q net falls on charges, but sales rise

July 27, 2012

Merck & Co.'s second-quarter net income fell 11.4 percent as slightly higher sales were offset by acquisition and restructuring costs. However, the drugmaker beat Wall Street expectations, and Merck shares jumped in early ...

J&J Q3 net income drops 7 percent on higher costs

October 16, 2012

Johnson & Johnson's third-quarter profit fell 7 percent as increased research and production costs offset higher sales for its medicines and medical devices and new revenue from its biggest acquisition ever.

Amgen 4Q profit drops 16 pct. on higher spending

January 23, 2013

Drugmaker Amgen Inc. on Wednesday posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other items offset higher sales for many of its biologic medicines. The results ...

Pfizer Q4 net jumps on sale of nutrition business

January 29, 2013

Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. The drugmaker's ...

Recommended for you

Where can I buy a chair like that? This app will tell you

August 23, 2016

If you think you have a knack for interior design, or just want to spruce up your own home, new technology developed by Cornell researchers may help you choose furnishings the way professionals do. And professionals may find ...

Sponge creates steam using ambient sunlight

August 22, 2016

How do you boil water? Eschewing the traditional kettle and flame, MIT engineers have invented a bubble-wrapped, sponge-like device that soaks up natural sunlight and heats water to boiling temperatures, generating steam ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.